Think it was some CLQ/AUZ thing. ie I'm invested in one, thus I...

First 86 Last

Share
Profile

Follow
GortonGums

5,116 Posts.

508

27/11/20

16:29

Post #: 49197071
Share

Originally posted by mbomb ↑

Whats the deal with these guys? disgruntled AUZ shareholders?

Not sure what the problem is here.

Company signed MOUs with 2 giant korean companies, company announced said MOUs to market. This is no doubt in shareholders best interests.

The company has not called an MOU something that it is not, nor has it embelished the MOU with ridiculous statements such as 'XYZ will pay for the plant', 'we dont have to fund it XYZ will' ala other companies.

There is a procedure that needs to take place here. Sign MOU, complete PP run, send samples to verify specifications, move to binding offtake/negotiate any financial assistance in financing package.

It would be completely irresponsible, and against shareholders bests interests for the company to keep shareholders in the dark until the final stage.

It is completely disingenuous to mock LG Chems involvement with cobalt blue. LG chem invested $6m USD at $1.10 in an early stage resource play. That COB hasnt been able to develop an economically viable resource project is hardly LG Chems fault. Similarly AUZs inability to close on their deal with SK Innovation is more so, in my belief, a reflection of the poor economics of the Sconi project. Note that the partnership was struck before the BFS (with only a limited PFS for a much smaller plant completed by metallica). This differs quite substantially to PM1 where a resource need not be proved up. The economics are already well known through the PFS and will be confirmed in the BFS.

Expand

Think it was some CLQ/AUZ thing. ie I'm invested in one, thus I must direct my scorn toward the other. Typical HC stuff, but times 100.

PM1 Price at posting: 4.2¢ Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

MXR

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

PCK

PainChek close to finding out if FDA approves its flagship app for use in dementia care

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 19 more messages in this thread...

First 86 Last

Add PM1 (ASX) to my watchlist

Think it was some CLQ/AUZ thing. ie I'm invested in one, thus I...

Top Stories

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News